- Home
- VLY vs RNA Comparison
VLY vs RNA Comparison
Compare VLY & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLY
- RNA
- Stock Information
- Founded
- VLY 1927
- RNA 2012
- Country
- VLY United States
- RNA United States
- Employees
- VLY N/A
- RNA N/A
- Industry
- VLY Major Banks
- RNA Biotechnology: Pharmaceutical Preparations
- Sector
- VLY Finance
- RNA Health Care
- Exchange
- VLY Nasdaq
- RNA Nasdaq
- Market Cap
- VLY 5.1B
- RNA 5.5B
- IPO Year
- VLY N/A
- RNA 2020
- Fundamental
- Price
- VLY $10.38
- RNA $42.56
- Analyst Decision
- VLY Hold
- RNA Strong Buy
- Analyst Count
- VLY 10
- RNA 9
- Target Price
- VLY $9.50
- RNA $63.22
- AVG Volume (30 Days)
- VLY 9.2M
- RNA 1.1M
- Earning Date
- VLY 10-24-2024
- RNA 11-07-2024
- Dividend Yield
- VLY 4.28%
- RNA N/A
- EPS Growth
- VLY N/A
- RNA N/A
- EPS
- VLY 0.62
- RNA N/A
- Revenue
- VLY $1,577,035,000.00
- RNA $10,117,000.00
- Revenue This Year
- VLY N/A
- RNA $19.33
- Revenue Next Year
- VLY $6.66
- RNA $10.35
- P/E Ratio
- VLY $16.45
- RNA N/A
- Revenue Growth
- VLY N/A
- RNA N/A
- 52 Week Low
- VLY $6.47
- RNA $5.97
- 52 Week High
- VLY $11.22
- RNA $56.00
- Technical
- Relative Strength Index (RSI)
- VLY 63.91
- RNA 43.93
- Support Level
- VLY $9.98
- RNA $39.50
- Resistance Level
- VLY $10.39
- RNA $56.00
- Average True Range (ATR)
- VLY 0.28
- RNA 3.65
- MACD
- VLY -0.00
- RNA -0.50
- Stochastic Oscillator
- VLY 80.65
- RNA 18.55
About VLY Valley National Bancorp
Valley National Bancorp is a bank holding company whose principal wholly-owned subsidiary is Valley National Bank. It provides a full range of commercial, retail, and trust and investment services largely through its offices and ATM network throughout northern and central New Jersey, New York City Long Island, Florida, and Alabama. The segments of the group are commercial lending, consumer lending, investment management, and corporate and other adjustments, of which key interest income is derived from the commercial lending segment. In recent years, the company has focused on acquiring companies that operate outside of traditional banking and has emphasized wealth and capital management.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.